GenScript Targeted LNP: Precision Delivery for Enhanced Therapeutics
The Targeted LNP service offers custom-made lipid nanoparticle formulations designed for precise therapeutic payload delivery. Enhanced with optimized antibodies and ligands, these LNPs enable targeted delivery to specific cell types, including T cells, lungs, spleen, tumors, brain, liver, and macrophages. Achieve efficient, tissue-specific delivery with GenScript’s advanced LNP technology.
Place your order directly with the manufacturer.
GenScript’s Targeted Lipid Nanoparticle (LNP) Service offers precision-engineered solutions for delivering therapeutic payloads to specific cell types and tissues. By integrating optimized antibodies and ligands such as CD3-Ab, 50DOTAP, COMP3, and Tri-GalNac, these LNPs enable highly efficient delivery of mRNA, saRNA, siRNA, proteins, and gene-editing tools. Designed for applications in gene therapy, oncology, immunotherapy, and metabolic diseases, this advanced platform ensures enhanced stability, bioavailability, and reduced off-target effects.
With customizable and scalable LNP formulations, GenScript’s service provides targeted delivery to T cells, lungs, spleen, tumors, brain, liver, and macrophages, improving therapeutic precision and efficacy. Whether for CRISPR-based gene editing, mRNA vaccine development, or CNS-targeted therapies, these tailored LNP solutions accelerate research and streamline the path to clinical success.
